World’s longest longevity1


Small size

Platinium is designed to facilitate the implant experience and improve patient comfort

  • Rounded edges and reduced pocket size
  • Allows for smaller incision and better fit for replacements

Ergoform Design

Platinium with its smooth and curved header also features ErgoformTM design for natural lead wrap around.

Breakthrough Technology

  • 40% reduced electronic consumption4
  • 20% improved battery capacity4
  • Reforming-free capacitors mean zero energy is wasted

Proven therapeutic Functions

  • SonR: Sensor-based CRT optimization
  • Parad+: Best-in-class arrhythmia discrimination with 99% specificity5
  • SafeR: Protects patients from deleterious effects of excessive RV pacing6
  • BTO: Protect patients with active resynchronization: the Brady Tachy Overlap
  • MP: Simultaneous Multipoint LV Pacing


  • 1. Projected longevity. LivaNova data on file. April 2017

  • 2. Functioning conditions for projected longevity: (real-life pacing conditions based on LivaNova data on file) Biventricular pacing in DDD mode, 30% in atrium, 100% in both ventricles, at 60 min-1, 600 Ohm, A and RV pacing amplitude 2.5 V, LV pacing amplitude 3V, 0.35 ms,3 max shock per year, sensor OFF, SonR ON, MP OFF. Remote ON: daily check, 4 follow-ups and 5 full alert reports per year. RF telemetry ON: 120min Implantation + 15min Discharge + 15min In-clinic quarterly FU. The longevities are calculated by taking into account 6 months storage.

  • 3. Warranty applies regardless of the pacing conditions and therapy frequency. For more details please refer to the following document supplied with the device: U666 - LIMITED WARRANTY for PLATINIUM ICD and CRT-D devices.

  • 4. Versus previous ICD generation (ParadymRF)

  • 5. Hintringer F, Deibl M, Berger T et al. Comparison of the Specificity of Implantable Dual Chamber Defibrillator Detection Algorithms. Pacing Clin Electrophysiol 2004; 27:976-82.

  • 6. Kolb C, Sturmer M, Sick P et al. Reduced Risk for Inappropriate Implantable Cardioverter-Defibrillator Shocks With Dual-Chamber Therapy Compared With Single-Chamber Therapy. Results of the randomized Option study. JACC Heart Failure 2014 Dec;2(6):611-9

  • 7. Refer to user’s manual furnished with the device for complete instructions for use

Hear from the experts

Sensor-based CRT optimization with SonR: experts discuss the tangible benefits of individualized, automatic optimization and the technology behind it.

Watch the videos
Watch the videos

The Key Results

Get an overview of the key results from the RESPOND-CRT trial including details on trial design and subgroup analyses.

Discover them
Discover them
Use of cookies

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.

OK, I agree
OK, I agree

This site is intended for healthcare professionals outside the United States of America. By continuing to use this site you are confirming that that you are a healthcare professional based outside the USA.

Contact Us

Request brochure

To request a brochure or any other materials on RESPOND-CRT, SonR or Platinium, please fill in your details below:

Send form
Send form

Access full results

I would like to receive*:

Send form
Send form

Arrange presentation

To arrange a presentation of the RESPOND-CRT results by a LivaNova representative, please fill in your details below:

Send form
Send form